Live Breaking News & Updates on Patterson Gynecology

Stay updated with breaking news from Patterson gynecology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Evofem Biosciences Announces Publication in American Journal of Obstetrics and Gynecology of AMPREVENCE Study of EVO100 for Chlamydia and Gonorrhea Prevention


Evofem Biosciences Announces Publication in American Journal of Obstetrics and Gynecology of AMPREVENCE Study of EVO100 for Chlamydia and Gonorrhea Prevention
News provided by
Share this article
Share this article
SAN DIEGO, March 16, 2021 /PRNewswire/  Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced publication of the pivotal manuscript from the AMPREVENCE clinical trial in the highly respected
American Journal of Obstetrics and Gynecology (AJOG). This double-blinded, placebo-controlled, multicenter study of EVO100 met its primary and secondary efficacy endpoints with statistically significant reductions in the risk of chlamydia and gonorrhea infections in women at high risk of infection.
We believe publication of this important manuscript in such a prestigious peer-reviewed journal further validates these impressive AMPREVENCE trial outcomes and brings us one step closer to being able to provide a woman-controlled, discreet option for preven ....

United States , Amy Raskopf , Evofem Bioscience , B Todd Chappell , Evofem Biosciences , Ellen Thomas , Brandi Howard , Centers For Disease , Drug Administration , Securities Exchange , Evofem Biosciences Inc , Evofem Bioscience Head Of Medical Affairs , American Journal , Evofem Bioscience Head , Patterson Gynecology , New Drug Application , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Disease Control , ஒன்றுபட்டது மாநிலங்களில் , ஏவோபெம் உயிர் அறிவியல் , எல்லன் தாமஸ் , பிராந்தி ஹோவர்ட் , மையங்கள் க்கு நோய் , பத்திரங்கள் பரிமாற்றம் ,